Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Mayes

Showing results (151-160 of 382) with videos related to

Pageof 39
Sort By:
Psychiatry Research|April 22, 2020
Symptom scores and medication treatment patterns in children with ADHD versus autismSusan D Mayes, James G Waxmonsky, Raman Baweja, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Sleep|May 2, 2012
Learning, attention/hyperactivity, and conduct problems as sequelae of excessive daytime sleepiness in a general population study of young childrenSusan L Calhoun, Julio Fernandez-Mendoza, Alexandros N Vgontzas, et al.
Journal of Clinical Epidemiology|April 1, 1995
The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan studyD Schottenfeld, C J Burns, B W Gillespie, et al.
Arthritis Care & Research|April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosisAlexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
The Cochrane Database of Systematic Reviews|July 29, 2022
Stem cell transplantation for systemic sclerosisSebastian Bruera, Harish Sidanmat, Donald A Molony, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2023
STAT6 suppression prevents bleomycin-induced dermal fibrosisJingjing Huang, Hydia Puente, Nancy E Wareing, et al.
The Journal of Rheumatology|June 3, 2010
The symptom burden index: development and initial findings from use with patients with systemic sclerosisMichael A Kallen, Maureen D Mayes, Yana L Kriseman, et al.
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
American Journal of Epidemiology|March 13, 2003
Scleroderma and solvent exposure among womenDavid H Garabrant, James V Lacey, Timothy J Laing, et al.
Pageof 39

Showing results (151-160 of 382) with videos related to

Sort By:
Pageof 39
Psychiatry Research|April 22, 2020
Symptom scores and medication treatment patterns in children with ADHD versus autismSusan D Mayes, James G Waxmonsky, Raman Baweja, et al.
Arthritis Research & Therapy|January 13, 2011
Toll-like receptor 3 upregulation by type I interferon in healthy and scleroderma dermal fibroblastsSandeep K Agarwal, Minghua Wu, Christopher K Livingston, et al.
Sleep|May 2, 2012
Learning, attention/hyperactivity, and conduct problems as sequelae of excessive daytime sleepiness in a general population study of young childrenSusan L Calhoun, Julio Fernandez-Mendoza, Alexandros N Vgontzas, et al.
Journal of Clinical Epidemiology|April 1, 1995
The design of a population-based case-control study of systemic sclerosis (scleroderma): commentary on the University of Michigan studyD Schottenfeld, C J Burns, B W Gillespie, et al.
Arthritis Care & Research|April 3, 2014
Correlates and responsiveness to change of measures of skin and musculoskeletal disease in early diffuse systemic sclerosisAlexandra B Wiese, Veronica J Berrocal, Daniel E Furst, et al.
The Cochrane Database of Systematic Reviews|July 29, 2022
Stem cell transplantation for systemic sclerosisSebastian Bruera, Harish Sidanmat, Donald A Molony, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 11, 2023
STAT6 suppression prevents bleomycin-induced dermal fibrosisJingjing Huang, Hydia Puente, Nancy E Wareing, et al.
The Journal of Rheumatology|June 3, 2010
The symptom burden index: development and initial findings from use with patients with systemic sclerosisMichael A Kallen, Maureen D Mayes, Yana L Kriseman, et al.
American Journal of Epidemiology|April 17, 1999
Petroleum distillate solvents as risk factors for undifferentiated connective tissue disease (UCTD)J V Lacey, D H Garabrant, T J Laing, et al.
American Journal of Epidemiology|March 13, 2003
Scleroderma and solvent exposure among womenDavid H Garabrant, James V Lacey, Timothy J Laing, et al.
Pageof 39